Research output per year
Research output per year
Search results
-
2003
Is HIF-1α a valid therapeutic target?
Pili, R. & Donehower, R. C., Apr 2 2003, In: Journal of the National Cancer Institute. 95, 7, p. 498-499 2 p.Research output: Contribution to journal › Editorial › peer-review
Open Access21 Scopus citations -
1995
Should anticancer drug doses be adjusted in the obese patient?
Baker, S. D., Grochow, L. B. & Donehower, R. C., Mar 1 1995, In: Journal of the National Cancer Institute. 87, 5, p. 333-334 2 p.Research output: Contribution to journal › Editorial › peer-review
29 Scopus citations -
1993
Therapeutic modalities: Editorial overview
Donehower, R. C. & Kirkwood, J. M., Jan 1 1993, In: Current opinion in oncology. 5, 6, p. 1001-1004 4 p.Research output: Contribution to journal › Editorial › peer-review
-
1991
Taxol: Twenty years later, the story unfolds
Rowinsky, E. K. & Donehower, R. C., Dec 18 1991, In: Journal of the National Cancer Institute. 83, 24, p. 1778-1781 4 p.Research output: Contribution to journal › Editorial › peer-review
86 Scopus citations -
Therapeutic modalities: Editorial overview
Donehower, R. & Kirkwood, J. M., 1991, In: Current opinion in oncology. 3, 6, p. 1035-1036 2 p.Research output: Contribution to journal › Editorial › peer-review
-
1990
Evaluating cancer chemotherapy by infusion
Donehower, R. C., Dec 19 1990, In: Journal of the National Cancer Institute. 82, 24, p. 1867-1868 2 p.Research output: Contribution to journal › Editorial › peer-review
Open Access4 Scopus citations -
1988
Understanding trimetrexate toxicity
Donehower, R. C., Oct 19 1988, In: Journal of the National Cancer Institute. 80, 16, p. 1268-1269 2 p.Research output: Contribution to journal › Editorial › peer-review
2 Scopus citations